Search Healthcare Professionals At Deciphera, we value the vital expertise and sincere commitment healthcare professionals provide to patients. Together we can change the way cancer is treated and bring hope to the patients we serve. Putting patients first A targeted approach Our clinical studies Funding and support Compliance and state disclosures Image Putting patients first We put patients first and they are the driving force in our mission to discover, develop, and deliver important new medicines for the treatment of cancer. At Deciphera, we recognize and appreciate the critical role that physicians, nurses, and various healthcare professionals play in the lives of people with cancer and in our fight to defeat cancer. Image Diseases we target LEARN MORE Image Our pipeline LEARN MORE Image A targeted approach with extraordinary potential Leveraging our deep expertise in kinase biology, we design kinase inhibitors targeting the switch pocket region of the kinase with the goal of developing potentially transformative medicines. OUR DISCOVERY PLATFORM Image Our clinical studies Deciphera is driven by our mission to discover, develop, and deliver important new medicines to patients for the treatment of cancer. We are grateful to the physicians and patients that are helping to advance our research programs through their participation in a clinical study. Clinical studies are currently underway for several of our investigational drug candidates that may have the potential to address unmet medical needs across multiple diseases. Clinical studies can lead to life-changing new medicines for people with cancer. LEARN MORE Funding and Support Through grants, sponsorships and research opportunities, Deciphera is committed to our patients, caregivers, advocacy groups, healthcare providers (HCPs) and researchers. LEARN MORE Image Personalized support and financial assistance for U.S. patients receiving QINLOCK VISIT SITE Image Compliance and state disclosures CALIFORNIA COMPLIANCE DECLARATION VERMONT DISCLOSURE COLORADO DISCLOSURE On this page you may select links to content published by persons not affiliated with Deciphera. The views expressed in these materials are those of the author and do not reflect the views of Deciphera. Additionally, the information contained in these materials may not be current. Deciphera disavows any obligation to correct or to update the information contained in these materials. twitter linkedin CONTACT US Main navigation Discovery Platform Pipeline Ripretinib Vimseltinib DCC-3116 Preclinical Pipeline Expanded Access Our Medicine QINLOCK® (ripretinib) Who We Are Management Board of Directors Join Us Open Positions Footer Utility Contact Us Terms of Use Privacy Policy Recruiting Privacy Policy Web Accessibility Statement © 2021 Deciphera Pharmaceuticals, Inc. QINLOCK and the QINLOCK logo are registered trademarks of Deciphera Pharmaceuticals, LLC. Deciphera and the Deciphera logo are trademarks of Deciphera Pharmaceuticals, LLC.